Autres langues

31/08 Afternoon Meeting: La Fed, el petróleo y un septiembre complicado
31/08 Die Fed, Öl und ein schwieriger September
31/08 The Fed, Oil And a Difficult September
31/08 Morning Meeting: Warsh geht in die Offensive
28/08 McKesson Reports Cybersecurity Incident
25/08 Equities Rise Despite US-Canada Trade Tensions
25/08 Equities Rise Intraday, Oil Falls as Markets Monitor Trade Developments
25/08 McKesson to Buy Precision Medicine in $2.25 Billion Deal
25/08 McKesson Corporation signed a definitive agreement to acquire Precision Medicine Group, LLC for approximately $2.3 billion.
25/08 McKesson to Acquire Precision Medicine Group for About $2.25 Billion
25/08 McKesson to Buy Precision Medicine Group for Roughly $2.25 Billion
25/08 McKesson strikes $2.25 billion Precision Medicine deal in clinical research bets
25/08 McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
20/08 Government Drops Statute Of Limitations Defense In McKesson Cost-sharing Challenge
19/08 McKesson's Specialty Drug Mix Helps Cushion Pricing Pressure, RBC Says
11/08 Mckesson Insider Sold Shares Worth $268,590, According to a Recent SEC Filing
05/08 Tranche Update on McKesson Corporation's Equity Buyback Plan announced on May 24, 2018.
05/08 McKesson raises annual profit forecast on strong growth in specialty drug business
05/08 McKesson: Fiscal Q1 Earnings Snapshot
05/08 McKesson Fiscal Q1 Adjusted Earnings, Revenue Rise; Lifts Fiscal 2027 Guidance
05/08 (MCK) McKesson Now Expects Fiscal 2027 Adjusted EPS Range $44.20-$45.00, vs. FactSet Est of $44.26
05/08 Earnings Flash (MCK) McKesson Posts Fiscal Q1 Adjusted EPS $9.93, vs. FactSet Est of $9.56
05/08 Earnings Flash (MCK) McKesson Posts Fiscal Q1 Revenue $105.38B, vs. FactSet Est of $103.88B
05/08 McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance
05/08 McKesson Corporation Reports Earnings Results for the First Quarter Ended June 30, 2026
Aucun résultat pour cette recherche